High affinity nanobodies block SARS-CoV-2 spike receptor binding domain interaction with human angiotensin converting enzyme

Thomas J. Esparza(Henry M. Jackson Foundation), David L. Brody(Washington University in St. Louis)

Scientific Reports

December 22, 2020

10.1038/s41598-020-79036-0

Cited by 123

Related Papers

Detection of Blast-Related Traumatic Brain Injury in U.S. Military Personnel

|New England Journal of Medicine|2011|596

Diversity of Amyloid-beta Proteoforms in the Alzheimer’s Disease Brain

|Scientific Reports|2017|165

Selection of single domain anti-transferrin receptor antibodies for blood-brain barrier transcytosis using a neurotensin based assay and histological assessment of target engagement in a mouse model of Alzheimer’s related amyloid-beta pathology

|PLoS ONE|2022|16

Pharmacokinetics of Single Domain Antibodies and Conjugated Nanoparticles Using a Hybrid near Infrared Method

|International Journal of Molecular Sciences|2021|15

High Affinity Nanobodies Block SARS-CoV-2 Spike Receptor Binding Domain Interaction with Human Angiotensin Converting Enzyme

|bioRxiv (Cold Spring Harbor Laboratory)|2020|11